Key Account Manager (m/f/x) – Immunology/Rare Diseases
CSL Innovation(2 months ago)
About this role
A Key Account Manager for CSL Behring's Spain Commercial Affiliate responsible for managing major accounts in immunology and rare diseases across either the North or South of Spain. The full-time, permanent, fully remote role reports to the Business Unit Head and supports the company’s market leadership by representing CSL to healthcare stakeholders and enabling cross-functional collaboration.
Required Skills
- Account Management
- CRM Management
- Tender Negotiation
- Hospital Sales
- Data Analysis
- Stakeholder Management
- Sales Planning
- Pharmacovigilance
- Cross-Functional Collaboration
- Market Access
Qualifications
- Scientific University Degree
- MBA (Preferred)
About CSL Innovation
csl.comCSL is a leading global biotechnology company dedicated to creating lifesaving medicines. With a portfolio that includes therapies for rare diseases, immune deficiencies, and vaccines for influenza, CSL's mission is rooted in innovation and public health. The organization comprises three distinct businesses: CSL Behring, focused on plasma-derived therapies; CSL Seqirus, specializing in influenza vaccines; and CSL Vifor, addressing iron deficiency and nephrology. Since its founding in 1916, CSL has been committed to ensuring access to essential treatments for patients in over 100 countries.
View more jobs at CSL Innovation →Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at CSL Innovation
Similar Jobs
Rare Diseases Registries Head
Sanofi(5 days ago)
Key Account Manager Rare Diseases North East (f/m/d)
Ipsen(18 days ago)
Key Account Manager Rare Diseases - Cluj
American Association of Physicists in Medicine(14 days ago)
Key Account Manager Rare Diseases South West (f/m/d)
Ipsen(18 days ago)
Key Account Manager Rare Diseases - Timisoara
American Association of Physicists in Medicine(14 days ago)
Director, Field Medical Affairs (Rare Diseases)
Regeneron Pharmaceuticals(2 months ago)